Most actively traded companies on the TSX, TSX Venture Exchange markets
Posted Jan 10, 2013 5:17 pm.
This article is more than 5 years old.
TORONTO – Some of the most active companies traded Thursday on the Toronto Stock Exchange and the TSX Venture Exchange:
Toronto Stock Exchange (12,599.74 up 77.50 points):
Bombardier Inc. (TSX:BBD.B). Transportation. Up nine cents, or 2.31 per cent, at $3.99 on 16,049,157 shares. The Montreal-based plane and train builder says improved debt markets have allowed it to raise US$2 billion, nearly two months after it was forced to delay its money-raising effort to help fund a number of development programs led by the CSeries plane.
Capstone Mining Corp. (TSX:CS). Miner. Up 26 cents, or 10.16 per cent, at $2.82 on 10,052,586 shares. The Vancouver-based company said it met its 2012 production targets.
Pacific Rubiales Energy Corp. (TSX:PRE). Oil and gas. Down 68 cents, or 2.94 per cent, at $22.47 on 8,489,326 shares.
B2Gold Corp. (TSX:BTO). Miner. Up 17 cents, or 4.66 per cent, at $3.82 on 6,753,060 shares.
Goldcorp Inc. (TSX:G). Miner. Up $1.26, or 3.56 per cent, at $36.68 on 5,863,659 shares.
Energy Fuels Inc. (TSX:EFR). Oil and gas. Up 1.5 cents, or 9.09 per cent, at 18 cents on 5,580,747 shares.
TSX Venture Exchange (1,240.08 up 10.97 points):
Castillian Resources Corp. (TSXV:CT). Miner. Up half a cent, or 20 per cent, at three cents on 8,037,412 shares.
Iona Energy Inc. (TSXV:INA). Oil and gas. Down three cents, or 5.08 per cent, at 62 cents on 4,601,583 shares.
Companies reporting major news:
Astral Media Inc. (TSX;ACM.A). Media. Up 31 cents, or 0.66 per cent, at $47.21 on 273,836 shares. It delivered its “single largest quarter” of growth as the specialty TV, radio and outdoor advertising company awaits regulatory approval of a friendly $3.38-billion takeover by BCE Inc.
Jean Coutu Group Inc. (TSX:PJC.A). Drug stores. Up 35 cents, or 2.46 per cent, at $14.57 on 211,341 shares. It expects that next week’s elimination of protection for dozens of brand-name drugs in Quebec will boost its growing generic drug company and continue to help offset future government price decreases.
